BTG Pactual Global Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,141
| Closed | -$509K | – | 51 |
|
|
2018
Q3 | $509K | Sell |
4,141
-8,390
| -67% | -$1.03M | 0.21% | 36 |
|
|
2018
Q2 | $1.23M | Buy |
12,531
+666
| +6% | +$65.4K | 0.36% | 40 |
|
|
2018
Q1 | $984K | Buy |
11,865
+1,393
| +13% | +$116K | 0.26% | 41 |
|
|
2017
Q4 | $813K | Buy |
10,472
+354
| +3% | +$27.5K | 0.3% | 35 |
|
|
2017
Q3 | $620K | Sell |
10,118
-704
| -7% | -$43.1K | 0.2% | 45 |
|
|
2017
Q2 | $498K | Buy |
10,822
+2,667
| +33% | +$123K | 0.14% | 53 |
|
|
2017
Q1 | $353K | Buy |
+8,155
| New | +$353K | 0.13% | 58 |
|